These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26756117)

  • 1. Bone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes.
    Starup-Linde J; Lykkeboe S; Gregersen S; Hauge EM; Langdahl BL; Handberg A; Vestergaard P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):928-36. PubMed ID: 26756117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.
    Szulc P; Bertholon C; Borel O; Marchand F; Chapurlat R
    J Bone Miner Res; 2013 Apr; 28(4):855-64. PubMed ID: 23165952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
    Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
    Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures.
    Heilmeier U; Carpenter DR; Patsch JM; Harnish R; Joseph GB; Burghardt AJ; Baum T; Schwartz AV; Lang TF; Link TM
    Osteoporos Int; 2015 Apr; 26(4):1283-93. PubMed ID: 25582311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
    Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
    Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
    Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
    Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
    García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
    J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.
    Amrein K; Dobnig H; Wagner D; Piswanger-Sölkner C; Pieber TR; Pilz S; Tomaschitz A; Dimai HP; Fahrleitner-Pammer A
    J Am Geriatr Soc; 2014 Jun; 62(6):1023-9. PubMed ID: 24779429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study.
    Szulc P; Boutroy S; Vilayphiou N; Schoppet M; Rauner M; Chapurlat R; Hamann C; Hofbauer LC
    J Bone Miner Res; 2013 Aug; 28(8):1760-70. PubMed ID: 23408601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
    Bilezikian JP; Josse RG; Eastell R; Lewiecki EM; Miller CG; Wooddell M; Northcutt AR; Kravitz BG; Paul G; Cobitz AR; Nino AJ; Fitzpatrick LA
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1519-28. PubMed ID: 23450056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bone structural basis for fracture risk in diabetes.
    Melton LJ; Riggs BL; Leibson CL; Achenbach SJ; Camp JJ; Bouxsein ML; Atkinson EJ; Robb RA; Khosla S
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4804-9. PubMed ID: 18796521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study.
    Iimori S; Mori Y; Akita W; Kuyama T; Takada S; Asai T; Kuwahara M; Sasaki S; Tsukamoto Y
    Nephrol Dial Transplant; 2012 Jan; 27(1):345-51. PubMed ID: 21652550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone cells and bone turnover in diabetes mellitus.
    Rubin MR
    Curr Osteoporos Rep; 2015 Jun; 13(3):186-91. PubMed ID: 25740570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone architecture and strength in diabetes mellitus].
    Okazaki R
    Clin Calcium; 2013 Jul; 23(7):1001-6. PubMed ID: 23811588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture Risk Assessment in Patients With Diabetes Mellitus.
    Poiana C; Capatina C
    J Clin Densitom; 2017; 20(3):432-443. PubMed ID: 28716499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.